Determination of metrifonate enantiomers in blood and brain samples using liquid chromatography on a chiral stationary phase coupled to tandem mass spectrometry.
A novel enantioselective assay is described for the simultaneous determination of the metrifonate enantiomers BAY z 7216 and BAY z 7217 in extracts of whole blood samples obtained from rats, mice, rabbits and Beagle dogs as well as in rat brain tissue using liquid chromatography tandem mass spectrometry (LC/MS/MS) with thermally and pneumatically assisted electrospray ionization (TurboIonSpray(R)). Chromatographic separation is achieved on a chiral normal phase column with a mobile phase containing 0.25% water only. The total run time per sample is 11.0 min giving chromatographic base line separation of the enantiomers. Compared with previous methods this assay offers a higher sample throughput, excellent ruggedness and higher sensitivity. The limits of quantification for each enantiomer are 5.00 microg/L from 0.5 mL whole blood and 7.50 ng/g (ppb) using 0.333 g brain tissue, respectively. Similar assay specifications have been derived for the two enantiomers. The method has been validated for the analysis of blood samples from low and high dosed preclinical pharmacokinetic and toxicokinetic studies, corresponding to two analytical working ranges like e.g. 5.00 to 1000 microg/L and 200 to 40000 microg/L (0. 200 to 40.0 mg/L). For rat brain tissue the validated concentration range is 7.50 to 750 ng/g (ppb).
Department of Preclinical Pharmacokinetics, Pharma Research Center, Bayer AG, D-42096 Wuppertal, Germany.
D
D
Zimmer
V
V
Muschalek
C
C
Müller
D000818:Animals; D001923:Brain Chemistry; D002138:Calibration; D002800:Cholinesterase Inhibitors / Q000032:analysis* / Q000097:blood; D004285:Dogs; D013058:Mass Spectrometry; D051379:Mice; D011786:Quality Control; D011817:Rabbits; D051381:Rats; D013237:Stereoisomerism; D014236:Trichlorfon / Q000032:analysis* / Q000097:blood
D002800:Cholinesterase Inhibitors; D014236:Trichlorfon